$796.87 Million in Sales Expected for Acadia Healthcare Company Inc (NASDAQ:ACHC) This Quarter

Brokerages forecast that Acadia Healthcare Company Inc (NASDAQ:ACHC) will post sales of $796.87 million for the current fiscal quarter, Zacks Investment Research reports. Eight analysts have issued estimates for Acadia Healthcare’s earnings, with the lowest sales estimate coming in at $781.74 million and the highest estimate coming in at $805.00 million. Acadia Healthcare reported sales of $765.74 million in the same quarter last year, which would suggest a positive year over year growth rate of 4.1%. The business is expected to announce its next quarterly earnings report on Monday, July 29th.

According to Zacks, analysts expect that Acadia Healthcare will report full year sales of $3.17 billion for the current financial year, with estimates ranging from $3.12 billion to $3.20 billion. For the next financial year, analysts anticipate that the business will post sales of $3.34 billion, with estimates ranging from $3.27 billion to $3.39 billion. Zacks’ sales calculations are an average based on a survey of sell-side analysts that that provide coverage for Acadia Healthcare.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Tuesday, April 30th. The company reported $0.39 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.35 by $0.04. The business had revenue of $760.60 million for the quarter, compared to analyst estimates of $762.02 million. Acadia Healthcare had a negative net margin of 6.50% and a positive return on equity of 7.33%. The business’s quarterly revenue was up 2.5% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.52 EPS.

Several research firms recently weighed in on ACHC. BidaskClub lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Friday, June 21st. TheStreet upgraded shares of Acadia Healthcare from a “d+” rating to a “c” rating in a report on Monday, June 17th. ValuEngine upgraded shares of Acadia Healthcare from a “strong sell” rating to a “sell” rating in a report on Wednesday, April 24th. Deutsche Bank set a $32.00 target price on shares of Acadia Healthcare and gave the company a “hold” rating in a report on Thursday, May 2nd. Finally, BMO Capital Markets boosted their price objective on shares of Acadia Healthcare from $33.00 to $36.00 and gave the stock a “market perform” rating in a report on Wednesday, May 1st. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and three have given a buy rating to the company. Acadia Healthcare currently has an average rating of “Hold” and an average target price of $36.80.

Hedge funds have recently modified their holdings of the business. Private Capital Group LLC lifted its holdings in Acadia Healthcare by 67.3% in the 1st quarter. Private Capital Group LLC now owns 865 shares of the company’s stock worth $25,000 after buying an additional 348 shares in the last quarter. Advisor Group Inc. lifted its holdings in Acadia Healthcare by 23.9% in the 4th quarter. Advisor Group Inc. now owns 3,039 shares of the company’s stock worth $78,000 after buying an additional 587 shares in the last quarter. Twin Tree Management LP lifted its holdings in Acadia Healthcare by 3,472.3% in the 1st quarter. Twin Tree Management LP now owns 2,965 shares of the company’s stock worth $87,000 after buying an additional 2,882 shares in the last quarter. Quantamental Technologies LLC acquired a new position in Acadia Healthcare in the 1st quarter worth $94,000. Finally, BNP Paribas Arbitrage SA lifted its holdings in Acadia Healthcare by 228.7% in the 1st quarter. BNP Paribas Arbitrage SA now owns 4,806 shares of the company’s stock worth $141,000 after buying an additional 3,344 shares in the last quarter.

NASDAQ:ACHC opened at $34.62 on Thursday. The company has a debt-to-equity ratio of 1.55, a current ratio of 1.07 and a quick ratio of 1.07. The firm has a market cap of $3.06 billion, a price-to-earnings ratio of 16.41, a price-to-earnings-growth ratio of 1.84 and a beta of 0.67. The company’s fifty day simple moving average is $33.61. Acadia Healthcare has a twelve month low of $24.27 and a twelve month high of $45.35.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico.

See Also: When can a hold rating present a buying opportunity?

Get a free copy of the Zacks research report on Acadia Healthcare (ACHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.